单位(元)天弘医药创新C(010655)资产负债表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
资产 |
银行存款 |
109,011,459 |
164,637,860 |
127,045,590 |
112,019,881 |
结算备付金 |
0 |
- |
1,076,854 |
332,751 |
存出保证金 |
462,105 |
720,001 |
1,017,203 |
1,323,592 |
交易性金融资产 |
998,448,678 |
1,046,020,962 |
1,139,007,362 |
1,091,327,221 |
其中:股票投资 |
998,448,678 |
1,046,020,962 |
1,139,007,362 |
1,091,327,221 |
基金投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
10,766,379 |
- |
8,358,384 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
861,427 |
- |
- |
应收申购款 |
1,165,312 |
990,960 |
470,422 |
1,771,300 |
其他资产 |
- |
- |
- |
- |
资产总计 |
1,109,087,554 |
1,223,997,588 |
1,268,617,431 |
1,215,133,129 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
3,182,609 |
38,118,205 |
6,557 |
235,324 |
应付赎回款 |
2,606,827 |
2,507,883 |
28,612,940 |
3,756,537 |
应付管理人报酬 |
947,859 |
1,003,212 |
1,030,356 |
918,818 |
应付托管费 |
189,572 |
250,803 |
257,589 |
229,704 |
应付销售服务费 |
132,701 |
144,563 |
117,841 |
108,645 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
543,631 |
517,508 |
1,437,827 |
740,733 |
负债合计 |
7,603,199 |
42,542,174 |
31,463,111 |
5,989,761 |
所有者权益 |
实收基金 |
1,333,503,335 |
1,432,721,180 |
1,309,567,545 |
1,307,170,442 |
未分配利润 |
-232,018,981 |
-251,265,766 |
-72,413,224 |
-98,027,074 |
所有者权益合计 |
1,101,484,355 |
1,181,455,414 |
1,237,154,321 |
1,209,143,368 |
负债和所有者权益总计 |
1,109,087,554 |
1,223,997,588 |
1,268,617,431 |
1,215,133,129 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。